Clinical Trial and Product Data

Uroplasty's commitment to provide physicians and patients with safe, effective products is backed by extensive clinical data.

Urgent ^® PC Neuromodulation System

For Urinary Disorders and Faecal Incontinence

Outpatient Neuromodulation, delivered through Percutaneous Tibial Nerve Stimulation (PTNS), has been the subject of multiple clinical publications.  Up to 80% of patients respond to PTNS treatment and see significant improvements in their symptoms.  Side-effects associated with the treatment are minimal and minor.  The Urgent PC Neuromodulation System is the only system available to provide PTNS treatment.

Macroplastique ^® Injectable Bulking Agent

For Stress Urinary Incontinence and Vesicoureteral Reflux

Widely used for more than 15 years with excellent clinical results, Macroplastique is a closely studied product with more than 50 articles pertaining to its safety and effectiveness in treating stress urinary incontinence in men and women as well as vesicoureteral reflux in children.

PTQ ^® Injectable Bulking Agent

For Faecal Incontinence

Clinical trials have demonstrated that PTQ Implants result in substantial improvement in Faecal Incontinence and quality of life in patients with internal sphincter dysfunction - without the risk of complications inherent in the use of more invasive surgical procedures.

VOX ^® Injectable Bulking Agent

For Vocal Cord Paralysis

Clinical data has shown that VOX implantation to be safe and effective in treating unilateral vocal cord palsy.  Results have been comparable to other techniques including laryngeal framework surgery.  Side-effects associated with the minimally invasive treatment are minor. 

0540050B 05/09